Bruker | BRKR - Current Liabilities


Bruker reported $1.2B in Current Liabilities for its fiscal quarter ending in June of 2026.





Current Liabilities Change Date
ABB USD 18.44B 71M Jun/2026
Agilent USD 2.27B 35M Mar/2026
Ametek USD 2.66B 97.54M Jun/2026
Bio Techne USD 153.28M 12.85M Mar/2026
Bio-Rad Laboratories USD 961.3M 44.3M Jun/2026
Bruker USD 1.2B 150.4M Jun/2026
Charles River Laboratories USD 1.09B 26.61M Mar/2026
Danaher USD 8.1B 645M Jun/2026
Fujikura JPY 277.92B 13.32B Mar/2026
Furukawa JPY 64.48B 18.99B Dec/2025
General Electric Aerospace USD 40.43B 403M Jun/2026
Hitachi JPY 7.17T 764M Jun/2026
Illumina USD 1.58B 12M Jun/2026
IQVIA Holdings USD 8.82B 486M Jun/2026
Mettler Toledo International USD 1.2B 92.14M Jun/2026
Mitsubishi Electric JPY 2.09T 188.53B Jun/2026
Mitsubishi Heavy Industries JPY 4.2T 65.85B Jun/2026
Myriad Genetics USD 130.7M 500K Jun/2026
Nikon Corporation JPY 328.3B 40.08B Mar/2026
Olympus JPY 436.87B 36.14B Mar/2026
Repligen USD 132.66M 6.45M Jun/2026
Revvity USD 1.28B 37.71M Jun/2026
Smiths GBP 1.01B 48M Jun/2026
Thermo Fisher Scientific USD 15.07B 448M Jun/2026
Waters USD 2.27B 1.03B Mar/2026